Latest Research
All publications from the Cancer3.AI database, newest first.
[Impact of conditioning intensity on transplant outcomes following allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic neoplasms: a multicenter retrospective cohort study].
Wang L, et al
A multicenter retrospective cohort study conducted across four Chinese transplant centers examined how the intensity of pre-transplant conditioning chemotherapy affects outcomes in 337 patients with myelodysplastic neoplasms (MDS) who underwent allogeneic hematopoietic stem cell transplantation between 2019 and 2025. Patients were stratified into three groups based on a transplant conditioning intensity (TCI) score: low (TCI-1), moderate (TCI-2), and high (TCI-3) intensity. The study found that three-year non-relapse mortality — death after transplant not caused by disease relapse — was dramatically higher in the high-intensity group at 27.1%, compared to just 7.7% and 8.3% in the low- and moderate-intensity groups, respectively. High conditioning intensity, age of 50 years or older, and a high comorbidity index were independently identified as risk factors for non-relapse mortality, and the three-year overall survival rate was lowest in the high-intensity group at 61.2%. These results, confirmed after rigorous statistical adjustment for baseline differences between groups, suggest that clinicians should carefully reconsider the use of high-intensity conditioning in MDS patients, particularly those who are older or have significant comorbidities, as moderate-intensity regimens appear to achieve comparable disease control with substantially less treatment-related mortality.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Source →An aging-related gene signature, featuring Cdkn2a, predicts prognosis and immunotherapy response in uterine corpus endometrial carcinoma.
Liu A, et al
Researchers investigated whether genes associated with the biological aging process could serve as reliable predictors of outcomes in uterine corpus endometrial carcinoma (UCEC), one of the most common gynecological cancers. By analyzing gene expression data, the team constructed an aging-related gene signature centered on the key senescence regulator Cdkn2a, along with several other aging-associated genes. This signature was found to effectively stratify UCEC patients into distinct risk groups, with high-risk patients showing significantly worse overall survival. Importantly, the signature also demonstrated the ability to predict how patients would respond to immunotherapy, a treatment increasingly used in endometrial cancer. These findings suggest that biological aging pathways play a meaningful role in shaping the tumor microenvironment and cancer progression in UCEC. Clinicians may in the future use this gene signature as a tool to personalize treatment strategies, particularly in selecting patients most likely to benefit from immunotherapy.
Discover oncology
Source →Cervical embryonal rhabdomyosarcoma beyond childhood: A case report and literature review.
Kokash D, et al
Researchers present a rare case of embryonal rhabdomyosarcoma (ERMS) of the uterine cervix in a 31-year-old adult woman, a cancer type that almost exclusively affects children and adolescents. The patient sought medical attention due to acute urinary retention, vaginal bleeding, and postcoital bleeding, and imaging revealed a large cervical mass compressing surrounding structures. Diagnosis was confirmed through surgical biopsy and immunohistochemical staining positive for desmin, myogenin, and MyoD1, markers characteristic of rhabdomyosarcoma. The case underscores that ERMS can mimic more common cervical conditions, making it a diagnostic challenge that requires careful histopathological evaluation. Clinicians are reminded that ultrasound and MRI are essential tools for initial assessment, and that the best outcomes depend on early diagnosis combined with surgery and adjuvant chemotherapy delivered by a multidisciplinary team. This report expands awareness that cervical ERMS, though exceedingly rare, must be considered in the differential diagnosis of cervical masses even in adult women.
Radiology case reports
Source →Diagnostic updates and research advances in AML-MR: Integrating molecular genetics and immune mechanisms.
Wang N, et al
A new review published in Leukemia Research examines the latest advances in understanding and treating acute myeloid leukemia, myelodysplasia-related (AML-MR), a distinct subtype formally recognized in the 2022 WHO classification. The review explores how refined molecular genetic biomarkers have improved diagnostic accuracy and risk stratification, enabling more personalized treatment approaches for affected patients. Researchers highlight that AML-MR development is closely linked to clonal hematopoietic abnormalities and a suppressed bone marrow immune microenvironment, which not only drives leukemic progression but also undermines the effectiveness of standard therapies. Emerging immunotherapies are showing promising results in overcoming this immunosuppressive environment and improving outcomes for high-risk patients. This comprehensive synthesis of classification criteria, molecular mechanisms, and targeted strategies aims to guide clinicians in optimizing patient management and to direct future research efforts in this challenging leukemia subtype.
Leukemia research
Source →[Correlation study between tumor location and pathological subtypes of neuroblastic tumors associated with opsoclonus myoclonus ataxia syndrome].
Shou R, et al
Researchers at Peking University First Hospital conducted a case-control study examining the relationship between tumor location and pathological subtypes in neuroblastic tumors (NBT) associated with opsoclonus myoclonus ataxia syndrome (OMAS), a rare neurological disorder in children. The study compared 34 pediatric patients with NBT-OMAS against 34 age- and sex-matched patients with NBT alone, analyzing data collected over 15 years from 2007 to 2022. Key findings revealed that in the NBT-OMAS group, 82% of tumors were located in the paraspinal sympathetic chain rather than the adrenal glands, and ganglioneuroblastoma (GNB) was the dominant pathological subtype, accounting for 59% of cases. In contrast, the NBT-only group was predominantly characterized by neuroblastoma (NB) originating from the adrenal glands. These results demonstrate a statistically significant correlation between paraspinal tumor location, more differentiated tumor subtypes, and the occurrence of OMAS, suggesting that tumor biology and anatomical position both influence the development of this paraneoplastic syndrome. Clinicians evaluating children with OMAS should be aware that the associated tumor is more likely to be a well-differentiated, paraspinal neuroblastic tumor, which may carry different prognostic and therapeutic implications.
Zhonghua er ke za zhi = Chinese journal of pediatrics
Source →